HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,168,981 | -16.3% | 1,620,551 | -20.4% | 0.01% | -13.3% |
| Q2 2023 | $173,369,816 | -43.8% | 2,036,291 | -45.4% | 0.02% | +7.1% |
| Q1 2023 | $308,648,564 | +218.1% | 3,729,892 | +202.4% | 0.01% | +40.0% |
| Q4 2022 | $97,019,415 | +107.0% | 1,233,559 | +94.9% | 0.01% | +100.0% |
| Q3 2022 | $46,861,000 | +83.1% | 633,005 | +61.2% | 0.01% | +66.7% |
| Q2 2022 | $25,593,000 | +13809.2% | 392,648 | +13342.2% | 0.00% | – |
| Q1 2022 | $184,000 | +84.0% | 2,921 | +54.6% | 0.00% | – |
| Q4 2021 | $100,000 | -81.7% | 1,889 | -75.6% | 0.00% | – |
| Q3 2021 | $546,000 | +0.6% | 7,740 | -4.9% | 0.00% | – |
| Q2 2021 | $543,000 | -99.8% | 8,143 | -99.6% | 0.00% | -100.0% |
| Q1 2021 | $249,893,000 | -15.3% | 2,251,084 | -9.4% | 0.02% | -19.2% |
| Q4 2020 | $294,934,000 | +49.9% | 2,483,654 | +10.2% | 0.03% | +30.0% |
| Q3 2020 | $196,722,000 | +22.9% | 2,254,699 | +26.2% | 0.02% | +11.1% |
| Q2 2020 | $160,031,000 | -6.8% | 1,786,854 | +3.7% | 0.02% | -25.0% |
| Q1 2020 | $171,689,000 | -29.6% | 1,722,744 | -18.8% | 0.02% | -11.1% |
| Q4 2019 | $243,853,000 | +2.1% | 2,122,311 | +12.1% | 0.03% | -6.9% |
| Q3 2019 | $238,747,000 | +160.5% | 1,892,709 | +148.5% | 0.03% | +163.6% |
| Q2 2019 | $91,641,000 | +21361.6% | 761,514 | +15501.6% | 0.01% | – |
| Q1 2019 | $427,000 | -12.1% | 4,881 | +0.5% | 0.00% | – |
| Q4 2018 | $486,000 | -14.0% | 4,859 | -1.5% | 0.00% | – |
| Q3 2018 | $565,000 | -47.4% | 4,933 | -58.8% | 0.00% | – |
| Q2 2018 | $1,074,000 | +144.6% | 11,971 | +99.5% | 0.00% | – |
| Q1 2018 | $439,000 | -74.2% | 6,000 | -79.5% | 0.00% | – |
| Q4 2017 | $1,700,000 | +11.2% | 29,263 | -14.1% | 0.00% | – |
| Q3 2017 | $1,529,000 | +13.9% | 34,081 | +0.2% | 0.00% | – |
| Q2 2017 | $1,342,000 | -3.8% | 34,005 | -1.1% | 0.00% | – |
| Q1 2017 | $1,395,000 | -80.4% | 34,396 | -80.5% | 0.00% | -100.0% |
| Q4 2016 | $7,108,000 | -82.2% | 176,824 | -83.9% | 0.00% | -80.0% |
| Q3 2016 | $39,889,000 | +1.4% | 1,101,588 | -18.8% | 0.01% | 0.0% |
| Q2 2016 | $39,342,000 | -17.1% | 1,357,079 | 0.0% | 0.01% | -28.6% |
| Q1 2016 | $47,470,000 | -23.7% | 1,357,079 | -29.7% | 0.01% | -12.5% |
| Q4 2015 | $62,233,000 | -0.1% | 1,930,291 | +0.1% | 0.01% | -11.1% |
| Q3 2015 | $62,310,000 | -33.8% | 1,927,926 | -15.3% | 0.01% | -25.0% |
| Q2 2015 | $94,160,000 | -8.5% | 2,276,602 | -0.6% | 0.01% | -7.7% |
| Q1 2015 | $102,923,000 | +20.5% | 2,291,270 | +0.4% | 0.01% | +18.2% |
| Q4 2014 | $85,440,000 | -4.3% | 2,283,270 | -10.7% | 0.01% | -8.3% |
| Q3 2014 | $89,290,000 | -3.1% | 2,556,984 | -2.1% | 0.01% | 0.0% |
| Q2 2014 | $92,150,000 | +26.6% | 2,611,974 | +17.0% | 0.01% | +20.0% |
| Q1 2014 | $72,767,000 | +129.8% | 2,232,800 | +197.1% | 0.01% | +150.0% |
| Q4 2013 | $31,663,000 | -0.1% | 751,560 | -5.4% | 0.00% | -20.0% |
| Q3 2013 | $31,696,000 | -32.0% | 794,808 | -29.5% | 0.01% | -37.5% |
| Q2 2013 | $46,627,000 | – | 1,127,628 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |